On the other hand, ALK-independent, “off-target” mechanisms, includes activation of bypass tracks and lineage changes, where the tumor cells effectively escape dependency on ALK which include: HER receptor family activation bypass mechanisms, MET amplification, MEK reactivation, PIK3CA mutation, KIT amplification, IGF1R activation, and SRC activation. The gene discussed is MET; the disease is neoplasm.